NCT04144868View on ClinicalTrials.gov

Normobaric Hyperoxia for Intracerebral Hemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
Normobaric HyperoxiaIntracerebral Hemorrhage
Interventions
DEVICE

Oxygen storage face masks and nasal catheter

Giving high-flow mask oxygen via oxygen storage face masks (100% O2, flow rate 8 L/min, 1 hour, four times daily, and 2 L/min via nasal catheter during intermittent periods, for 7 days) immediately at admission.

DEVICE

Nasal catheter

Giving 2 L/min flow of 100% O2 via nasal catheter at admission for 24 hours daily for 7 days.

Trial Locations (1)

100053

Xuanwu Hospital, Captial Medical University, Beijing

All Listed Sponsors
collaborator

Jiujiang University Affiliated Hospital

OTHER_GOV

lead

Capital Medical University

OTHER

NCT04144868 - Normobaric Hyperoxia for Intracerebral Hemorrhage | Biotech Hunter | Biotech Hunter